Originator And Biosimilar Natalizumab Win English Funding For Highly Active MS

 
• By Neena Brizmohun
  
NHS Written On Wooden Cubes. Symbol Of Healthcare In England
Originator natalizumab and its biosimilar version is to be funded for use via the NHS for certain MS patients (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Pink Sheet